Press release: Glasgow medical firm showcases the best of UK life sciences sector

This British Science Week, Glasgow-based company, Tissue Solutions Ltd, demonstrates why the UK is a world leader in life sciences and medical research.

Founded in 2007, Tissue Solutions is a global virtual biobank providing fully consented human tissue and biomaterials to pharmaceutical and biotech companies across Europe, Asia and the U.S to develop new drugs and diagnostics.

The company has since gained international reputation as a high-quality ethical provider of human tissue, working to support scientific discoveries and improve clinical success for oncological diseases, autoimmune diseases and more.

Dr Mike Short, Chief Scientific Adviser at the Department for International Trade, said:

Companies like Tissue Solutions ensure that the UK remains a world leader in medical research and innovation. In 2018, the UK exported nearly £25 billion in medicinal and pharmaceutical products alone, showing the global demand for British scientific excellence.

In 2017, the UK Government launched the Life Sciences Industrial Strategy which demonstrates our commitment to the sector. Therefore, I would encourage companies to get in touch with DIT through great.gov.uk if they need support to enter new markets overseas.

The UK has one of the strongest and most vibrant health and life sciences industries in the world, which supports 240,000 jobs and generates a turnover of around £70 billion per year.

British Science Week is an annual celebration of science, technology, engineering and maths (STEM) across the UK. The event encourages organisations, professionals, and science communicators to get involved in STEM events and activities.

The UK is the number one destination for life sciences inward investment in Europe, and is home to the top 25 global pharmaceutical companies and top 30 medical technology companies.

With 20 employees based in its Glasgow office, Tissue Solutions operates a virtual tissue bank with a client base that includes over 80% of pharmaceutical and life sciences companies in the Fortune 1000.

Dr Morag McFarlane, Chief Executive Officer at Tissue Solutions, said:

Ethically sourced human biomaterials lead to new treatments and are increasingly important for scientific breakthroughs.

We are committed to providing human tissues to researchers worldwide and exporting has always been central to our business. We have grown a lot since 2007, with support from DIT, and now provide a range of tissue related services to the global research community.